Malay Malay
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Berita Terkini

Terapi Gen Penyelidikan Meningkatkan Pengeluaran FIX

 

Data Menunjukkan Potensi Terapi Gene Roctavia untuk Hemofilia A

 

Terapi Gene Roctavian Mencegah Pendarahan Selama 5 Tahun, Data menunjukkan

 

Terapi Gen Hemofilia B AMT-061 Paparan Data Percubaan yang Selamat, Berkesan

 

Kembali ke atas
Image

Please enable the javascript to submit this form

Introduksi

Disokong oleh geran pendidikan daripada Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics dan uniQure, Inc.

SSL penting